.png)
48th Borderline Product Evaluation Committee decided to reject all the products (in any stage-Classification, Sample Import License and Registration) Which are export purposes and not to consider any clarification regarding the export purposes.
(Date: 27 October 2022)
National Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka